Structure-based virtual screening to get news scaffold inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis

Archive ouverte

Coluccia, Antonio | La Regina, Giuseppe | Barilone, Nathalie | Lisa, Maria Natalia | Brancale, Andrea | André-Leroux, Gwenaëlle | Alzari, Pedro M. | Silvestri, Romano

Edité par CCSD ; Bentham Science Publishers -

In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 mu M, which provides a novel scaffold for further improvement of PknB inhibitors.

Suggestions

Du même auteur

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.

Archive ouverte | Famiglini, Valeria | CCSD

International audience. HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) represent one of the most significant classes of drugs for the treatment of AIDS/HIV infection. Over the past two decades severa...

New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.

Archive ouverte | La Regina, Giuseppe | CCSD

New indolylarylsulfone (IAS) derivatives bearing nitrogen containing substituents at the indole-2-carboxamide inhibited the HIV-1 WT in MT-4 cells at low nanomolar concentrations. In particular, compound 9 was uniformly effective ...

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy

Archive ouverte | Saponaro, Concetta | CCSD

International audience. Nuclear activated β-catenin plays a causative role in colorectal cancers (CRC) but remains an elusive therapeutic target. Using human CRC cells harboring different Wnt/β-catenin pathway mutat...

Chargement des enrichissements...